{ "items" : [
    { "id" : "http://webisa.webdatacommons.org/267197401"
      "properties" : {
        "http://www.w3.org/1999/02/22-rdf-syntax-ns#type" : [ "http://www.w3.org/ns/prov#Entity" ] ,
        "http://www.w3.org/ns/prov#value" : [ "In this study, 260 people with relapsing forms of MS took 44 mcg of reformulated Rebif three times weekly, and the results were compared with historical data from the EVIDENCE study (in which the original Rebif was compared to Avonex." ] ,
        "http://www.w3.org/ns/prov#wasQuotedFrom" : [ "pediatricmscenter.org" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/471781926"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/267197401" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/52823794"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/267197401"] } } }
